Novo Biosciences' Convertible Note Round

Novo Biosciences raised a round of funding on July 17, 2015.

Novo Biosciences is a regenerative medicine company developing small molecule therapies that reactivate and stimulate innate healing abilities in humans and animals. Its most recent lead molecule, ZF1…

Articles about Novo Biosciences' Convertible Note Round: